SCHEMBL4298918

SCHEMBL4298918

Cc1cccc(Cl)c1S(=O)(=O)N(CCOCC(=O)N1CCC(OCC[N+]2([O-])CCCC2)(c2cccc(F)c2)CC1)C1CC1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.34
BDKRB1 P46663 17/20 0.34
ALOX15 P16050 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4292696 0.88 BDKRB1 (0.37) RORCBDKRB1
SCHEMBL13660769 0.85 CCL5 (0.31) BDKRB1
SCHEMBL4295145 0.81 BDKRB1 (0.36) RORCBDKRB1ALOX15
SCHEMBL3313157 0.81 RORC (0.36) RORCBDKRB1
SCHEMBL701988 0.80 BDKRB1 (0.39) BDKRB1
SCHEMBL4305153 0.78 BDKRB1 (0.35) RORCBDKRB1
SCHEMBL13660770 0.73 CCR5 (0.33) BDKRB1
SCHEMBL703257 0.73 BDKRB1 (0.40) BDKRB1
SCHEMBL703459 0.72 BDKRB1 (0.38) BDKRB1
SCHEMBL13660774 0.72 BDKRB1 (0.44) BDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US claimed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US claimed
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 RORC 3972/4885BDKRB1 1/4885ALOX15 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.